Advisory Group Recommendations on Priorities for the IARC Monographs [2019]
Public Domain
-
2019/06/01
Details
-
Personal Author:Bahadori T ; Barupal DK ; Beland FA ; Belpoggi F ; Benbrahim-Tallaa L ; Berrington de Gonzalez A ; Bouvard V ; Browne P ; Comba, Paul ; Cree IA ; Dai M ; Daniels, Robert D. ; Demers PA ; El Ghissassi F ; Ferreccio C ; Girschik J ; Grigoriev OA ; Grosse Y ; Guyton KZ ; Hall AL ; Hong YC ; Hoover RN ; Kanno J ; Kogevinas M ; Korenjak M ; Lachenmeier DW ; Lasfargues G ; Malekzadeh R ; Marques MM ; Masten S ; McCormack V ; Müller K ; Newton R ; Norat T ; Pappas JJ ; Queiroz Moreira C ; Rodríguez T ; Rodríguez-Guzmán J ; Schubauer-Berigan, Mary K. ; Schüz J ; Sewram V ; Straif K ; Turner MC ; Zavadil J ; Zeise L
-
Corporate Authors:
-
Description:An Advisory Group of 29 scientists from 18 countries met in March, 2019, to recommend priorities for the International Agency for Research on Cancer (IARC) Monographs programme during 2020-24. IARC periodically convenes such advisory groups to ensure that the Monographs evaluations reflect the current state of scientific evidence relevant to carcinogenicity. A detailed report of the Advisory Group will be published subsequently. Agents not previously evaluated by IARC Monographs: Haloacetic acids (and other disinfection byproducts); Metalworking fluids; Cannabis smoking; fertility treatment; glucocorticoids; Salmonella typhi; sedentary behaviour; tetracyclines and other photosensitising drugs; Cupferron; gasoline oxygenated additives; gentian violet; glycidamide; malachite green and leucomalachite green; oxymetholone; pentabromodiphenyl ethers; vinclozolin; Breast implants; dietary salt intake; neonatal phototherapy; poor oral hygiene; Aspartame; Arecoline; carbon disulphide; electronic nicotine delivery systems and nicotine; human cytomegalovirus; parabens. Agents previously evaluated by IARC Monographs: Automotive gasoline (leaded and unleaded); carbaryl; malaria; Acrylamide; acrylonitrile; some anthracyclines; coal dust; combustion of biomass; domestic talc products; firefighting exposure; metallic nickel; some pyrethroids (ie, permethrin, cypermethrin, deltamethrin); Aniline; acrolein; methyl eugenol and isoeugenol; multi-walled carbon nanotubes; non-ionising radiation (radiofrequency); some perfluorinated compounds (eg, perfluorooctanoic acid); Ostrogen:oestradiol and oestrogen-progestogens; hydrochlorothiazide; Merkel cell polyomavirus; perchloroethylene; very hot foods and beverages; 1,1,1-trichloroethane; weapons-grade alloy (tungsten, nickel, and cobalt); Acetaldehyde; bisphenol A; cobalt and cobalt compounds; crotonaldehyde; cyclopeptide cyanotoxins; fumonisin B1; inorganic lead compounds; isoprene; o-anisidine. Medium priority agents: 2,3-butanedione (diacetyl); alachlor; biphenyl; chlorinated paraffins; chlorpyrifos; c.i. direct blue 218; diphenylamine; hydrazobenzene; indole-3-carbinol; mancozeb; nanomaterials (eg, titanium dioxide or nanosilica); nitrogen dioxide; o-benzyl-p-chlorophenol; ozone; pendimethalin; sleep; styrene-acrylonitrile trimer; terbufos; tris(chloropropyl)phosphate; Aflatoxins; anthracene; antimony trioxide; atrazine; bromate compounds; dimethyl hydrogen phosphite; furan; N-methylolacrylamide; p-nitrotoluene; Schistosoma mansoni; tris(2-chloroethyl) phosphate; tobacco smoking (including second hand). Low priority agents: 2-hydroxy-4-methoxybenzophenone; aluminium; androstenedione; butyl methacrylate; cinidon ethyl; dysbiotic microbiota; fonofos; furmecyclox; isoflavones; isophorone; laboratory work and occupation as a chemist; methanol; S-ethyl-N,N,-dipropylthiocarbamate; semiconductor manufacturing; Sucralose; 1,1-dimethylhydrazine; benzophenone-1; carbon black; catechol; chlordecone; cumene; dichloromethane; hepatitis D virus; human papillomavirus (beta cutaneous and some alpha mucosal types); Opisthorchis felineus; outdoor air pollution; pyrrolizidine alkaloids; selenium and selenium compounds. Description provided by NIOSH
-
Subjects:
-
Keywords:
-
ISSN:1470-2045
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:20
-
Issue:6
-
NIOSHTIC Number:nn:20056823
-
Citation:Lancet Oncol 2019 Jun; 20(6):763-764
-
CAS Registry Number:
- (-)-Nicotine (CAS RN 54-11-5)
- 1,1,1-Trichloroethane (CAS RN 71-55-6)
- 1,1-Dimethylhydrazine (CAS RN 57-14-7)
- 2,2-Bis(4-hydroxyphenyl)propane (CAS RN 80-05-7)
- 2-Methoxyaniline (CAS RN 90-04-0)
- 4-Nitrotoluene (CAS RN 99-99-0)
- Acetaldehyde (CAS RN 75-07-0)
- Acrolein (CAS RN 107-02-8)
- Acrylamide (CAS RN 79-06-1)
- Alachlor (CAS RN 15972-60-8)
- Aluminum (CAS RN 7429-90-5)
- Aniline (CAS RN 62-53-3)
- Anthracene (CAS RN 120-12-7)
- Antimony trioxide (CAS RN 1309-64-4)
- Atrazine (CAS RN 1912-24-9)
- Benzophenone (CAS RN 119-61-9)
- Biphenyl (CAS RN 92-52-4)
- Butanedione (CAS RN 431-03-8)
- Carbon black (CAS RN 1333-86-4)
- Carbon disulfide (CAS RN 75-15-0)
- Carbon nanotubes (CAS RN 308068-56-6)
- Catechol (CAS RN 120-80-9)
- Chlorpyrifos (CAS RN 2921-88-2)
- Cobalt (CAS RN 7440-48-4)
- Crotonaldehyde (CAS RN 4170-30-3)
- Cumene (CAS RN 98-82-8)
- Dichloromethane (CAS RN 75-09-2)
- Diphenylamine (CAS RN 122-39-4)
- Fonofos (CAS RN 944-22-9)
- Fumonisin-B1 (CAS RN 116355-83-0)
- Furan (CAS RN 110-00-9)
- Hydrazobenzene (CAS RN 122-66-7)
- Hydrochlorothiazide (CAS RN 58-93-5)
- Isophorone (CAS RN 78-59-1)
- Isoprene (CAS RN 78-79-5)
- Lead (CAS RN 7439-92-1)
- Mancozeb (CAS RN 8018-01-7)
- Methanol (CAS RN 67-56-1)
- Nickel (CAS RN 7440-02-0)
- Nitrogen dioxide (CAS RN 10102-44-0)
- Ozone (CAS RN 10028-15-6)
- Perfluorodecanoic acid (CAS RN 335-76-2)
- S-Ethyl dipropylthiocarbamate (CAS RN 759-94-4)
- Selenium (CAS RN 7782-49-2)
- Tetrachloroethylene (CAS RN 127-18-4)
- Titania (CAS RN 13463-67-7)
- Tris(2-chloroisopropyl) phosphate (CAS RN 13674-84-5)
- Tungsten (CAS RN 7440-33-7)
-
Federal Fiscal Year:2019
-
Peer Reviewed:False
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:028709c2b183b2f7dc81572fdb14e2a05b270e5fea37960ff4ab16e6805461aa80bbb1bc6a97caa04ac3db7185d1f071724c0c7e38ea7ef744503a1c7158beb2
Related Documents
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like